• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝伐单抗通过维持 HIV-1 Gag 螺旋束对称来抑制病毒成熟。

Preservation of HIV-1 Gag Helical Bundle Symmetry by Bevirimat Is Central to Maturation Inhibition.

机构信息

Department of Chemistry, Chicago Center for Theoretical Chemistry, Institute for Biophysical Dynamics, and James Franck Institute, The University of Chicago, Chicago, Illinois 60637, United States.

Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, Virginia 22908, United States.

出版信息

J Am Chem Soc. 2021 Nov 17;143(45):19137-19148. doi: 10.1021/jacs.1c08922. Epub 2021 Nov 5.

DOI:10.1021/jacs.1c08922
PMID:34739240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8610020/
Abstract

The assembly and maturation of human immunodeficiency virus type 1 (HIV-1) require proteolytic cleavage of the Gag polyprotein. The rate-limiting step resides at the junction between the capsid protein CA and spacer peptide 1, which assembles as a six-helix bundle (6HB). Bevirimat (BVM), the first-in-class maturation inhibitor drug, targets the 6HB and impedes proteolytic cleavage, yet the molecular mechanisms of its activity, and relatedly, the escape mechanisms of mutant viruses, remain unclear. Here, we employed extensive molecular dynamics (MD) simulations and free energy calculations to quantitatively investigate molecular structure-activity relationships, comparing wild-type and mutant viruses in the presence and absence of BVM and inositol hexakisphosphate (IP6), an assembly cofactor. Our analysis shows that the efficacy of BVM is directly correlated with preservation of 6-fold symmetry in the 6HB, which exists as an ensemble of structural states. We identified two primary escape mechanisms, and both lead to loss of symmetry, thereby facilitating helix uncoiling to aid access of protease. Our findings also highlight specific interactions that can be targeted for improved inhibitor activity and support the use of MD simulations for future inhibitor design.

摘要

人类免疫缺陷病毒 1 型(HIV-1)的组装和成熟需要对 Gag 多蛋白进行蛋白水解切割。限速步骤位于衣壳蛋白 CA 和间隔肽 1 之间的连接处,它们组装成六螺旋束(6HB)。贝伐单抗(BVM)是首个上市的成熟抑制剂药物,靶向 6HB 并阻碍蛋白水解切割,但它的作用机制及其相关的突变病毒逃逸机制仍不清楚。在这里,我们采用广泛的分子动力学(MD)模拟和自由能计算来定量研究结构-活性关系,比较了野生型和突变型病毒在存在和不存在 BVM 和肌醇六磷酸(IP6)的情况下的结构-活性关系,IP6 是一种组装辅助因子。我们的分析表明,BVM 的功效与 6HB 中的六倍对称性的保持直接相关,6HB 作为结构状态的集合存在。我们确定了两种主要的逃逸机制,这两种机制都导致对称性丧失,从而促进螺旋解卷,以帮助蛋白酶进入。我们的研究结果还突出了可以针对提高抑制剂活性的特定相互作用,并支持使用 MD 模拟进行未来的抑制剂设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/2d7a6cd29fec/ja1c08922_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/c2562ef422ed/ja1c08922_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/f76813ce8c9e/ja1c08922_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/b0ec150e5f81/ja1c08922_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/c74a38f4052d/ja1c08922_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/d3796b1538dc/ja1c08922_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/2d7a6cd29fec/ja1c08922_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/c2562ef422ed/ja1c08922_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/f76813ce8c9e/ja1c08922_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/b0ec150e5f81/ja1c08922_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/c74a38f4052d/ja1c08922_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/d3796b1538dc/ja1c08922_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30d7/8610020/2d7a6cd29fec/ja1c08922_0006.jpg

相似文献

1
Preservation of HIV-1 Gag Helical Bundle Symmetry by Bevirimat Is Central to Maturation Inhibition.贝伐单抗通过维持 HIV-1 Gag 螺旋束对称来抑制病毒成熟。
J Am Chem Soc. 2021 Nov 17;143(45):19137-19148. doi: 10.1021/jacs.1c08922. Epub 2021 Nov 5.
2
MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat.HIV-1 Gag CTD-SP1 的 MicroED 结构揭示了与成熟抑制剂贝维利姆的结合相互作用。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13258-13263. doi: 10.1073/pnas.1806806115. Epub 2018 Dec 10.
3
Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.HIV-1 成熟抑制剂对病毒样颗粒中 CA-SP1 连接环螺旋结构和动力学的影响。
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10286-10293. doi: 10.1073/pnas.1917755117. Epub 2020 Apr 27.
4
The Effect of Inositol Hexakisphosphate on HIV-1 Particle Production and Infectivity can be Modulated by Mutations that Affect the Stability of the Immature Gag Lattice.六磷酸肌醇对 HIV-1 颗粒生成和感染力的影响可以通过影响不成熟衣壳晶格稳定性的突变来调节。
J Mol Biol. 2023 Jun 1;435(11):168037. doi: 10.1016/j.jmb.2023.168037. Epub 2023 Jun 16.
5
Structural and functional insights into the HIV-1 maturation inhibitor binding pocket.HIV-1 成熟抑制剂结合口袋的结构与功能见解。
PLoS Pathog. 2012;8(11):e1002997. doi: 10.1371/journal.ppat.1002997. Epub 2012 Nov 8.
6
Resistance to Second-Generation HIV-1 Maturation Inhibitors.对第二代 HIV-1 成熟抑制剂的耐药性。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.02017-18. Print 2019 Mar 15.
7
Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors.机制研究与建模揭示了HIV-1成熟抑制剂对Gag多态性病毒产生差异抑制作用的起源。
PLoS Pathog. 2016 Nov 28;12(11):e1005990. doi: 10.1371/journal.ppat.1005990. eCollection 2016 Nov.
8
HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice.HIV-1 成熟抑制剂贝维利姆抑制不成熟的 Gag 晶格。
J Virol. 2011 Feb;85(4):1420-8. doi: 10.1128/JVI.01926-10. Epub 2010 Nov 24.
9
Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.烷基胺贝维拉马衍生物是强效且具有广泛活性的HIV-1成熟抑制剂。
Antimicrob Agents Chemother. 2015 Oct 19;60(1):190-7. doi: 10.1128/AAC.02121-15. Print 2016 Jan.
10
Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.未暴露于贝韦利姆的 HIV-1 感染者分离株对贝韦利姆的表型敏感性。
Antimicrob Agents Chemother. 2010 Jun;54(6):2345-53. doi: 10.1128/AAC.01784-09. Epub 2010 Mar 22.

引用本文的文献

1
Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937.VH3739937 作为 HIV-1 成熟抑制剂的临床前特征。
Viruses. 2024 Sep 24;16(10):1508. doi: 10.3390/v16101508.
2
Structural insights into inhibitor mechanisms on immature HIV-1 Gag lattice revealed by high-resolution single-particle cryo-EM.高分辨率单颗粒冷冻电镜揭示未成熟HIV-1 Gag晶格上抑制剂作用机制的结构见解
bioRxiv. 2024 Oct 9:2024.10.09.617473. doi: 10.1101/2024.10.09.617473.
3
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.探索 HIV-1 成熟:抗病毒药物开发的新前沿。

本文引用的文献

1
Immature HIV-1 assembles from Gag dimers leaving partial hexamers at lattice edges as potential substrates for proteolytic maturation.不成熟的 HIV-1 由 Gag 二聚体组装而成,在晶格边缘留下部分六聚体作为潜在的蛋白酶成熟底物。
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). doi: 10.1073/pnas.2020054118.
2
Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.HIV-1 成熟抑制剂对病毒样颗粒中 CA-SP1 连接环螺旋结构和动力学的影响。
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10286-10293. doi: 10.1073/pnas.1917755117. Epub 2020 Apr 27.
3
TRIM5α self-assembly and compartmentalization of the HIV-1 viral capsid.
Viruses. 2024 Sep 6;16(9):1423. doi: 10.3390/v16091423.
4
Selected Plant Triterpenoids and Their Derivatives as Antiviral Agents.植物三萜类化合物及其衍生物作为抗病毒药物的研究进展。
Molecules. 2023 Nov 22;28(23):7718. doi: 10.3390/molecules28237718.
5
Conformational transitions of the HIV-1 Gag polyprotein upon multimerization and gRNA binding.HIV-1 Gag 多聚体化和 gRNA 结合时的构象转变。
Biophys J. 2024 Jan 2;123(1):42-56. doi: 10.1016/j.bpj.2023.11.017. Epub 2023 Nov 18.
6
Sub-stoichiometric Modulation of Viral Targets-Potent Antiviral Agents That Exploit Target Vulnerability.病毒靶点的亚化学计量调节——利用靶点脆弱性的强效抗病毒剂
ACS Med Chem Lett. 2023 Jul 11;14(8):1021-1030. doi: 10.1021/acsmedchemlett.3c00279. eCollection 2023 Aug 10.
7
Structural basis of HIV-1 maturation inhibitor binding and activity.HIV-1 成熟抑制剂结合和活性的结构基础。
Nat Commun. 2023 Mar 4;14(1):1237. doi: 10.1038/s41467-023-36569-y.
8
Anti-HIV Potential of Beesioside I Derivatives as Maturation Inhibitors: Synthesis, 3D-QSAR, Molecular Docking and Molecular Dynamics Simulations.蜜蜂皂甙 I 衍生物作为成熟抑制剂的抗 HIV 潜力:合成、3D-QSAR、分子对接和分子动力学模拟。
Int J Mol Sci. 2023 Jan 11;24(2):1430. doi: 10.3390/ijms24021430.
9
Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232.HIV-2 和 SIV 对成熟抑制剂 GSK2838232 的固有耐药性。
PLoS One. 2023 Jan 18;18(1):e0280568. doi: 10.1371/journal.pone.0280568. eCollection 2023.
TRIM5α 自我组装和 HIV-1 病毒衣壳的区室化。
Nat Commun. 2020 Mar 11;11(1):1307. doi: 10.1038/s41467-020-15106-1.
4
Off-Pathway Assembly: A Broad-Spectrum Mechanism of Action for Drugs That Undermine Controlled HIV-1 Viral Capsid Formation.非经典组装:破坏 HIV-1 病毒衣壳形成的控制性药物的广谱作用机制。
J Am Chem Soc. 2019 Jul 3;141(26):10214-10224. doi: 10.1021/jacs.9b01413. Epub 2019 Jun 19.
5
Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation.深入了解 EP-39 的作用机制,这是一种抑制 HIV-1 成熟的 bevirimat 衍生物。
Antiviral Res. 2019 Apr;164:162-175. doi: 10.1016/j.antiviral.2019.02.014. Epub 2019 Feb 27.
6
Resistance to Second-Generation HIV-1 Maturation Inhibitors.对第二代 HIV-1 成熟抑制剂的耐药性。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.02017-18. Print 2019 Mar 15.
7
MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat.HIV-1 Gag CTD-SP1 的 MicroED 结构揭示了与成熟抑制剂贝维利姆的结合相互作用。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13258-13263. doi: 10.1073/pnas.1806806115. Epub 2018 Dec 10.
8
High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation.高分辨率的 HIV-1 Gag 切割突变体结构决定了病毒成熟的结构转换。
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9401-E9410. doi: 10.1073/pnas.1811237115. Epub 2018 Sep 14.
9
Inositol phosphates are assembly co-factors for HIV-1.肌醇磷酸是 HIV-1 的组装协同因子。
Nature. 2018 Aug;560(7719):509-512. doi: 10.1038/s41586-018-0396-4. Epub 2018 Aug 1.
10
Quenching protein dynamics interferes with HIV capsid maturation.抑制蛋白质动力学会干扰 HIV 衣壳成熟。
Nat Commun. 2017 Nov 24;8(1):1779. doi: 10.1038/s41467-017-01856-y.